Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabis and Cannabinoids: Kinetics and Interactions
Brian C. Foster, Hanan Abramovici, Cory S. Harris
The American Journal of Medicine (2019) Vol. 132, Iss. 11, pp. 1266-1270
Closed Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association
Robert L. Page, Larry A. Allen, Robert A. Kloner, et al.
Circulation (2020) Vol. 142, Iss. 10
Open Access | Times Cited: 176
ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids
Shalini Shah, Eric S. Schwenk, Rakesh V. Sondekoppam, et al.
Regional Anesthesia & Pain Medicine (2023) Vol. 48, Iss. 3, pp. 97-117
Open Access | Times Cited: 57
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline
Ilana M. Braun, Kari Bohlke, Donald I. Abrams, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 13, pp. 1575-1593
Closed Access | Times Cited: 19
Simultaneous detection of salivary Δ9-tetrahydrocannabinol and alcohol using a Wearable Electrochemical Ring Sensor
Rupesh K. Mishra, Juliane R. Sempionatto, Zhanhong Li, et al.
Talanta (2020) Vol. 211, pp. 120757-120757
Open Access | Times Cited: 117
Marijuana Use in Patients With Cardiovascular Disease
Ersilia M. DeFilippis, Navkaranbir S. Bajaj, Amitoj Singh, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 3, pp. 320-332
Open Access | Times Cited: 110
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
Integrative Therapies in Cancer Care: An Update on the Guidelines
Krisstina Gowin, Meri Muminovic, Suzanna M. Zick, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 12
An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans
Dolly Andrea Caicedo, Clara Pérez‐Mañá, Magı́ Farré, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 319-319
Open Access | Times Cited: 1
“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations
Caroline A. MacCallum, Lindsay A. Lo, Michael Boivin
European Journal of Internal Medicine (2021) Vol. 89, pp. 10-18
Open Access | Times Cited: 52
Analgesic Potential of Terpenes Derived fromCannabis sativa
Erika Liktor‐Busa, Attila Keresztes, Justin LaVigne, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1269-1297
Open Access | Times Cited: 48
A Coala‐T‐Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment
Marisa C. Weiss, Julianne Hibbs, Meghan Buckley, et al.
Cancer (2021) Vol. 128, Iss. 1, pp. 160-168
Open Access | Times Cited: 44
Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug
Shiri Procaccia, Gil M. Lewitus, Carni Lipson Feder, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response
Yaron Ilan
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 28
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2119-2119
Open Access | Times Cited: 17
The Impact of Feeding Cannabidiol (CBD) Containing Treats on Canine Response to a Noise-Induced Fear Response Test
Elizabeth M. Morris, Susanna E. Kitts-Morgan, Dawn Spangler, et al.
Frontiers in Veterinary Science (2020) Vol. 7
Open Access | Times Cited: 40
Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain
Caroline A. MacCallum, Lauren Eadie, Alasdair M. Barr, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36
Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
Lauren Eadie, Lindsay A. Lo, April Christiansen, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 35
Pharmacovigilance on cannabidiol as an antiepileptic agent
Ilaria Ammendolia, Carmen Mannucci, Luigi Cardia, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Research Progress on Cannabinoids in Cannabis (Cannabis sativa L.) in China
Xiangping Sun
Molecules (2023) Vol. 28, Iss. 9, pp. 3806-3806
Open Access | Times Cited: 14
Predicting therapy dropout in chronic pain management: a machine learning approach to cannabis treatment
Anna Visibelli, Rebecca Finetti, Bianca Roncaglia, et al.
Frontiers in Artificial Intelligence (2025) Vol. 8
Open Access
Medicinal Chemistry and Detoxification of Poisonous Plants in Traditional Medicine: A Comprehensive Review
Inder Pal Singh, Ankur Kumar Tanwar, Debanjan Chatterjee, et al.
Toxicon (2025), pp. 108307-108307
Closed Access
Marijuana and the Pediatric Population
Sadhana Dharmapuri, Katy Miller, Jonathan D. Klein
PEDIATRICS (2020) Vol. 146, Iss. 2
Closed Access | Times Cited: 38
The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations
Samuel Vaughn, Jeffrey R. Strawn, Ethan A. Poweleit, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 7, pp. 615-615
Open Access | Times Cited: 27
Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
Kevin F. Boehnke, Winfried Häuser, Mary‐Ann Fitzcharles
Current Rheumatology Reports (2022) Vol. 24, Iss. 7, pp. 238-246
Open Access | Times Cited: 20
Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review
Aleksandra Zielińska, Piotr Eder, Jacek Karczewski, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top